About Nanofantek
Nanofantek is a company based in Gangseo (South Korea) founded in 2018. It operates as a B2B and D2C. Nanofantek offers products and services including Nanofiber 8well plate and 24well plate (co-culture). Nanofantek operates in a competitive market with competitors including Acera Surgical, KLISBio, Bergen Carbon Solutions, CelluComp and ANF Technology, among others.
- Headquarter Gangseo, South Korea
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website nanofaentech.com
- Legal Name (주)나노팬텍
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
Associated legal entities of Nanofantek
Nanofantek operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | – | – | – | View details |
Products & Services of Nanofantek
Nanofantek offers a comprehensive portfolio of products and services, including Nanofiber 8well plate and 24well plate (co-culture).
Plate for 3D cell culture in research applications
Plate for co-culture in immune cell therapy processes
Competitors of Nanofantek
Nanofantek operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Acera Surgical, KLISBio, Bergen Carbon Solutions, CelluComp and ANF Technology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| acera-surgical.com | 2013 | St. Louis, United States | $6.32M | – | Synthetic electrospun scaffolds are provided for regenerative medical uses. | |
| klis.bio | 2013 | Bresso, Italy | $8.58M | – | Developer of regenerative implantable products by using silk fibroins | |
| bergencarbonsolutions.com | 2016 | Bergen, Norway | – | 30 | Carbon nanofibers are produced from carbon dioxide via separation technology. | |
| cellucomp.com | 2006 | Burntisland, United Kingdom | $9.14M | 6 | Nano-fibers from root vegetables are developed for industrial applications. | |
| anftechnology.com | 2010 | Tallinn, Estonia | $10M | – | Nano alumina fibers are produced as universal material enhancers. | |
| fiberiotech.com | 2009 | Mcallen, United States | $17.89M | – | Develops high-throughput nanofiber systems and materials for industrial applications. | |
| dipolematerials.com | 2015 | Baltimore, United States | – | – | Developer of nano-fiber for tissue engineering, water filtration, & technical textiles | |
| nanostatics.com | 2005 | Circleville, United States | $11.13M | – | Specializes in nanofibers for high-performance materials. | |
| verdextech.com | 2011 | Richmond, United States | – | – | Produces advanced nanofibers using green technology for industrial and healthcare uses. | |
| engain.co.kr | 2012 | Goyang, South Korea | – | – | Hydrogel and bio-gel for biological parameter measurement are supplied. |
Detailed competitors of Nanofantek
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Nanofantek
10 companies that operate in the same segment as Nanofantek (Cell Therapy), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 300 | |
T-cell-based immunotherapies for cancer treatment are developed. | 2000 | Tubingen, Baden-wurttemberg, Germany | USD 236.4 M | USD 54.47 M | 423 | |
Engineered T-cell immunotherapies are developed for cancer and auto-immune diseases. | 2015 | London, England, United Kingdom | USD 181.37 M | USD 75.56 M | 647 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 | |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment | 2015 | Cambridge, Massachusetts, United States | USD 158 M | – | 58 | |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms. | 2011 | San Francisco, California, United States | USD 36.13 M | – | 36 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Cue Biopharma is focused on developing immunotherapy solutions. | 2015 | Cambridge, Massachusetts, United States | USD 10 M | USD 27.47 M | 41 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nanofantek
Nanofantek was founded in 2018.
Nanofantek is headquartered in Gangseo, South Korea.
Nanofaentech is a biotechnology company that focuses on innovative products for cell culture and therapy. They produce items like nanofiber plates designed for 3D cell culture and immune cell therapy, supporting research in life sciences. The company operates from its main office in Daegu, South Korea, and engages in technology development to advance healthcare solutions. Their activities include manufacturing and selling specialized plates for scientific applications, aiming to contribute to the biotechnology sector through reliable tools.
Nanofantek's top competitors include Acera Surgical, CelluComp and KLISBio.
Nanofantek offers Nanofiber 8well plate and 24well plate (co-culture).
Nanofantek operates through ,.